Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Transplantation | 24 | 2022 | 1309 | 3.170 |
Why?
|
Graft Rejection | 27 | 2022 | 4492 | 1.400 |
Why?
|
Swine, Miniature | 31 | 2018 | 965 | 1.340 |
Why?
|
Immune Tolerance | 13 | 2022 | 2323 | 1.050 |
Why?
|
Graft Survival | 18 | 2025 | 3887 | 0.980 |
Why?
|
Major Histocompatibility Complex | 10 | 2017 | 877 | 0.940 |
Why?
|
Heart Transplantation | 23 | 2025 | 3301 | 0.920 |
Why?
|
Transplantation, Homologous | 23 | 2022 | 4833 | 0.880 |
Why?
|
Swine | 39 | 2022 | 5995 | 0.820 |
Why?
|
Histocompatibility Antigens Class II | 6 | 2008 | 1441 | 0.770 |
Why?
|
Histocompatibility Antigens Class I | 9 | 2009 | 1361 | 0.700 |
Why?
|
Chimerism | 2 | 2017 | 156 | 0.590 |
Why?
|
Immunosuppressive Agents | 16 | 2022 | 4206 | 0.590 |
Why?
|
Histocompatibility | 2 | 2015 | 321 | 0.570 |
Why?
|
Breast Implantation | 1 | 2020 | 225 | 0.560 |
Why?
|
Tissue Donors | 8 | 2025 | 2381 | 0.550 |
Why?
|
Transplantation Tolerance | 8 | 2025 | 633 | 0.550 |
Why?
|
Papain | 1 | 2015 | 66 | 0.510 |
Why?
|
Kidney Transplantation | 11 | 2025 | 4262 | 0.510 |
Why?
|
Antibodies, Anti-Idiotypic | 3 | 2016 | 355 | 0.500 |
Why?
|
Macaca fascicularis | 5 | 2025 | 912 | 0.500 |
Why?
|
Brain Death | 3 | 2018 | 359 | 0.480 |
Why?
|
Sarcoma, Myeloid | 1 | 2015 | 52 | 0.480 |
Why?
|
Transplantation, Heterologous | 10 | 2022 | 2393 | 0.470 |
Why?
|
Histocompatibility Antigens | 1 | 2015 | 479 | 0.450 |
Why?
|
Esophageal Stenosis | 1 | 2015 | 196 | 0.450 |
Why?
|
Transplantation Chimera | 4 | 2017 | 594 | 0.420 |
Why?
|
Immunoglobulin M | 3 | 2016 | 1528 | 0.420 |
Why?
|
Tracheal Stenosis | 1 | 2015 | 228 | 0.420 |
Why?
|
Peptide Hydrolases | 1 | 2015 | 610 | 0.410 |
Why?
|
Organ Preservation | 3 | 2015 | 393 | 0.410 |
Why?
|
Meat | 1 | 2015 | 588 | 0.400 |
Why?
|
Thoracic Surgery | 1 | 2018 | 727 | 0.390 |
Why?
|
Foreign Bodies | 1 | 2015 | 403 | 0.370 |
Why?
|
Teaching | 1 | 2018 | 1171 | 0.360 |
Why?
|
Gastroesophageal Reflux | 2 | 2008 | 836 | 0.360 |
Why?
|
Histocompatibility Testing | 5 | 2015 | 716 | 0.350 |
Why?
|
Models, Animal | 7 | 2017 | 2120 | 0.340 |
Why?
|
Mammaplasty | 1 | 2020 | 1268 | 0.330 |
Why?
|
Chest Wall Oscillation | 1 | 2009 | 16 | 0.320 |
Why?
|
Organ Transplantation | 6 | 2022 | 1176 | 0.320 |
Why?
|
Bone Marrow Transplantation | 4 | 2025 | 2709 | 0.320 |
Why?
|
Ethanol | 1 | 2014 | 1331 | 0.290 |
Why?
|
Postoperative Complications | 8 | 2020 | 15832 | 0.290 |
Why?
|
Retroviridae Infections | 2 | 1998 | 148 | 0.290 |
Why?
|
Thoracic Surgical Procedures | 2 | 2009 | 350 | 0.280 |
Why?
|
Leukocytes | 1 | 2015 | 2035 | 0.280 |
Why?
|
Thymectomy | 3 | 2006 | 200 | 0.280 |
Why?
|
Pulmonary Artery | 3 | 2019 | 1946 | 0.270 |
Why?
|
Length of Stay | 2 | 2020 | 6498 | 0.270 |
Why?
|
Animals | 57 | 2025 | 169246 | 0.260 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2420 | 0.260 |
Why?
|
Myocytes, Cardiac | 2 | 2014 | 1681 | 0.260 |
Why?
|
Family Practice | 1 | 2009 | 509 | 0.260 |
Why?
|
Antibodies, Monoclonal | 6 | 2016 | 9263 | 0.250 |
Why?
|
Hematopoiesis | 1 | 2015 | 2059 | 0.250 |
Why?
|
HLA Antigens | 2 | 2008 | 1334 | 0.250 |
Why?
|
Pneumonectomy | 5 | 2019 | 1156 | 0.240 |
Why?
|
Papio | 6 | 2001 | 671 | 0.240 |
Why?
|
Donor Selection | 1 | 2007 | 240 | 0.240 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2062 | 0.240 |
Why?
|
Pulmonary Alveoli | 1 | 2008 | 665 | 0.240 |
Why?
|
Cyclosporine | 6 | 2005 | 777 | 0.240 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2016 | 2145 | 0.240 |
Why?
|
Lung Diseases | 1 | 2015 | 1944 | 0.230 |
Why?
|
Thymus Gland | 3 | 2024 | 1266 | 0.230 |
Why?
|
Bronchiolitis Obliterans | 2 | 2008 | 221 | 0.230 |
Why?
|
Endothelium, Vascular | 2 | 2008 | 4427 | 0.220 |
Why?
|
Lung | 7 | 2019 | 10099 | 0.220 |
Why?
|
Ventricular Function, Left | 2 | 2016 | 3941 | 0.220 |
Why?
|
Chemokines | 1 | 2008 | 963 | 0.220 |
Why?
|
Myocardium | 2 | 2016 | 4788 | 0.220 |
Why?
|
Brachiocephalic Trunk | 1 | 2003 | 40 | 0.210 |
Why?
|
Leiomyoma | 2 | 2005 | 644 | 0.210 |
Why?
|
Isoantigens | 1 | 2005 | 562 | 0.210 |
Why?
|
Deltaretrovirus Infections | 2 | 2001 | 25 | 0.200 |
Why?
|
Lung Neoplasms | 8 | 2019 | 13586 | 0.200 |
Why?
|
Transplantation, Autologous | 2 | 2020 | 2120 | 0.200 |
Why?
|
Postoperative Care | 1 | 2009 | 1480 | 0.200 |
Why?
|
Tracheal Diseases | 1 | 2003 | 118 | 0.200 |
Why?
|
Pleural Effusion | 1 | 2005 | 344 | 0.200 |
Why?
|
Pulmonary Circulation | 2 | 2007 | 745 | 0.200 |
Why?
|
Esophageal Neoplasms | 3 | 2012 | 1668 | 0.190 |
Why?
|
Esophageal Perforation | 1 | 2022 | 65 | 0.190 |
Why?
|
Fistula | 1 | 2003 | 213 | 0.190 |
Why?
|
Simian T-lymphotropic virus 1 | 1 | 2001 | 6 | 0.190 |
Why?
|
Alcohol Drinking | 1 | 2014 | 4045 | 0.190 |
Why?
|
Heart | 5 | 2015 | 4446 | 0.180 |
Why?
|
Monkey Diseases | 1 | 2001 | 71 | 0.180 |
Why?
|
Respiratory Mucosa | 1 | 2004 | 439 | 0.180 |
Why?
|
Tacrolimus | 4 | 2015 | 750 | 0.180 |
Why?
|
Antilymphocyte Serum | 2 | 2015 | 492 | 0.180 |
Why?
|
Esophagectomy | 4 | 2022 | 481 | 0.170 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2003 | 282 | 0.170 |
Why?
|
Immunity, Innate | 4 | 2008 | 3080 | 0.170 |
Why?
|
Apoptosis | 3 | 2015 | 9523 | 0.160 |
Why?
|
Tissue and Organ Harvesting | 3 | 2014 | 373 | 0.160 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2010 | 5432 | 0.160 |
Why?
|
Galactosyltransferases | 3 | 2011 | 284 | 0.150 |
Why?
|
Diverticulum, Esophageal | 1 | 2017 | 14 | 0.150 |
Why?
|
Gammaretrovirus | 1 | 1997 | 24 | 0.140 |
Why?
|
Isoantibodies | 2 | 2015 | 681 | 0.140 |
Why?
|
Pneumonia | 1 | 2009 | 2163 | 0.140 |
Why?
|
Coronary Vessels | 6 | 2016 | 3124 | 0.140 |
Why?
|
Patient Satisfaction | 1 | 2009 | 3488 | 0.130 |
Why?
|
Retroviridae | 1 | 1998 | 846 | 0.130 |
Why?
|
Tracheostomy | 2 | 2015 | 430 | 0.130 |
Why?
|
Breast Implants | 1 | 2020 | 414 | 0.130 |
Why?
|
Peptides | 2 | 2007 | 4354 | 0.130 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2007 | 1483 | 0.130 |
Why?
|
Perfusion | 3 | 2015 | 1401 | 0.130 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2015 | 317 | 0.120 |
Why?
|
Thoracotomy | 1 | 2017 | 374 | 0.120 |
Why?
|
Vascular Diseases | 2 | 2003 | 1162 | 0.120 |
Why?
|
Thoracic Surgery, Video-Assisted | 2 | 2010 | 297 | 0.120 |
Why?
|
Endothelial Cells | 1 | 2008 | 3589 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2005 | 4648 | 0.120 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11519 | 0.120 |
Why?
|
Horses | 1 | 2015 | 295 | 0.110 |
Why?
|
Flow Cytometry | 6 | 2015 | 5902 | 0.110 |
Why?
|
Myosin Heavy Chains | 1 | 2016 | 404 | 0.110 |
Why?
|
Tumor Virus Infections | 1 | 1997 | 437 | 0.110 |
Why?
|
Circadian Rhythm | 5 | 2000 | 2593 | 0.110 |
Why?
|
Humans | 57 | 2022 | 768166 | 0.110 |
Why?
|
Receptors, Interleukin-6 | 1 | 2015 | 224 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2001 | 1375 | 0.110 |
Why?
|
Deglutition Disorders | 2 | 2017 | 640 | 0.110 |
Why?
|
Macrophages | 1 | 2008 | 5799 | 0.100 |
Why?
|
Radial Artery | 1 | 2014 | 188 | 0.100 |
Why?
|
Time Factors | 11 | 2015 | 40218 | 0.100 |
Why?
|
Pleura | 1 | 2013 | 248 | 0.100 |
Why?
|
Hypersensitivity, Delayed | 3 | 2011 | 491 | 0.100 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2015 | 1353 | 0.100 |
Why?
|
Thyrotropin | 2 | 1996 | 834 | 0.100 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2015 | 1801 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 3814 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2020 | 59629 | 0.090 |
Why?
|
Middle Aged | 21 | 2020 | 223492 | 0.090 |
Why?
|
Signal Transduction | 1 | 2014 | 23645 | 0.090 |
Why?
|
Cardiac Myosins | 1 | 2011 | 128 | 0.090 |
Why?
|
Transplantation Conditioning | 1 | 2017 | 1601 | 0.090 |
Why?
|
Troponin T | 1 | 2016 | 787 | 0.090 |
Why?
|
Immunologic Memory | 2 | 2015 | 1377 | 0.090 |
Why?
|
Aged | 19 | 2022 | 171504 | 0.090 |
Why?
|
Echocardiography | 3 | 2016 | 5047 | 0.090 |
Why?
|
T-Lymphocytes | 4 | 2015 | 10266 | 0.090 |
Why?
|
Biopsy | 2 | 2015 | 6793 | 0.090 |
Why?
|
Cryopreservation | 1 | 2015 | 733 | 0.090 |
Why?
|
Arthritis, Rheumatoid | 1 | 2005 | 3781 | 0.080 |
Why?
|
Pleurodesis | 1 | 2010 | 49 | 0.080 |
Why?
|
Disease Models, Animal | 2 | 2016 | 18349 | 0.080 |
Why?
|
Light | 2 | 1999 | 1355 | 0.080 |
Why?
|
Stem Cells | 2 | 2015 | 3537 | 0.080 |
Why?
|
Ischemia | 1 | 2018 | 1900 | 0.080 |
Why?
|
Pleural Neoplasms | 1 | 2013 | 612 | 0.080 |
Why?
|
Databases, Factual | 3 | 2020 | 8080 | 0.080 |
Why?
|
Vena Cava, Superior | 1 | 2009 | 197 | 0.080 |
Why?
|
Male | 27 | 2025 | 364719 | 0.080 |
Why?
|
Chronic Disease | 4 | 2005 | 9384 | 0.080 |
Why?
|
Interleukin-1 | 1 | 2012 | 1252 | 0.070 |
Why?
|
Whole-Body Irradiation | 1 | 2009 | 435 | 0.070 |
Why?
|
Gene Knockout Techniques | 1 | 2011 | 806 | 0.070 |
Why?
|
beta-Thromboglobulin | 1 | 2007 | 20 | 0.070 |
Why?
|
Mesothelioma | 1 | 2013 | 811 | 0.070 |
Why?
|
Biological Clocks | 2 | 2000 | 321 | 0.070 |
Why?
|
Female | 23 | 2020 | 397192 | 0.070 |
Why?
|
Skin Transplantation | 2 | 2013 | 1096 | 0.070 |
Why?
|
Tissue and Organ Procurement | 3 | 2015 | 986 | 0.070 |
Why?
|
Gastric Outlet Obstruction | 1 | 2006 | 55 | 0.070 |
Why?
|
Pylorus | 1 | 2006 | 86 | 0.070 |
Why?
|
Human T-lymphotropic virus 1 | 2 | 2001 | 143 | 0.070 |
Why?
|
Mediastinal Neoplasms | 1 | 2009 | 403 | 0.070 |
Why?
|
Interleukin-10 | 1 | 2012 | 1183 | 0.070 |
Why?
|
Catheterization | 2 | 2014 | 1430 | 0.070 |
Why?
|
Coronary Disease | 2 | 1998 | 5919 | 0.070 |
Why?
|
ABO Blood-Group System | 1 | 2009 | 381 | 0.070 |
Why?
|
Endosonography | 1 | 2010 | 626 | 0.070 |
Why?
|
Gastrostomy | 1 | 2008 | 325 | 0.060 |
Why?
|
Young Adult | 5 | 2020 | 60066 | 0.060 |
Why?
|
Acute Disease | 5 | 2011 | 7243 | 0.060 |
Why?
|
Cell Transplantation | 1 | 2008 | 475 | 0.060 |
Why?
|
Immunization | 2 | 2011 | 1219 | 0.060 |
Why?
|
Macaca mulatta | 4 | 2024 | 2363 | 0.060 |
Why?
|
Epitopes | 2 | 2011 | 2528 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2014 | 2191 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 13014 | 0.060 |
Why?
|
Rheumatoid Factor | 1 | 2005 | 185 | 0.060 |
Why?
|
Adult | 16 | 2020 | 223646 | 0.060 |
Why?
|
Homozygote | 2 | 2006 | 1779 | 0.060 |
Why?
|
Rats, Inbred WF | 1 | 2004 | 140 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2496 | 0.060 |
Why?
|
Endoscopy | 1 | 2014 | 1854 | 0.060 |
Why?
|
Safety | 1 | 2009 | 1159 | 0.060 |
Why?
|
Thoracoscopy | 1 | 2005 | 186 | 0.060 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2014 | 1566 | 0.050 |
Why?
|
Mycophenolic Acid | 1 | 2005 | 348 | 0.050 |
Why?
|
Endothelin-1 | 2 | 2015 | 296 | 0.050 |
Why?
|
Chondroma | 1 | 2003 | 53 | 0.050 |
Why?
|
Kidney | 2 | 2015 | 7064 | 0.050 |
Why?
|
Immunoglobulin G | 3 | 2006 | 4568 | 0.050 |
Why?
|
Papilloma | 1 | 2003 | 143 | 0.050 |
Why?
|
Autoantibodies | 1 | 2011 | 2121 | 0.050 |
Why?
|
Neoplasm Staging | 4 | 2012 | 11244 | 0.050 |
Why?
|
Esophageal Fistula | 1 | 2002 | 60 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2012 | 3228 | 0.050 |
Why?
|
Interferon-gamma | 2 | 2008 | 3160 | 0.050 |
Why?
|
Bronchial Fistula | 1 | 2002 | 83 | 0.050 |
Why?
|
Genetic Variation | 1 | 2017 | 6611 | 0.050 |
Why?
|
Polyps | 1 | 2003 | 200 | 0.050 |
Why?
|
Minor Histocompatibility Loci | 1 | 2001 | 16 | 0.050 |
Why?
|
Cebidae | 1 | 2001 | 21 | 0.050 |
Why?
|
Adolescent | 7 | 2020 | 89169 | 0.050 |
Why?
|
Carcinoma, Bronchogenic | 1 | 2001 | 86 | 0.050 |
Why?
|
Lipoma | 1 | 2003 | 296 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2022 | 81762 | 0.050 |
Why?
|
Animals, Laboratory | 1 | 2001 | 46 | 0.050 |
Why?
|
Barrett Esophagus | 1 | 2005 | 495 | 0.050 |
Why?
|
Thymoma | 1 | 2002 | 188 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20760 | 0.050 |
Why?
|
Animals, Wild | 1 | 2001 | 78 | 0.050 |
Why?
|
Body Constitution | 1 | 2001 | 273 | 0.040 |
Why?
|
Prednisone | 1 | 2005 | 1567 | 0.040 |
Why?
|
Immunoglobulin Idiotypes | 2 | 1991 | 201 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4352 | 0.040 |
Why?
|
Hospitals, General | 2 | 2017 | 809 | 0.040 |
Why?
|
Teratoma | 1 | 2003 | 405 | 0.040 |
Why?
|
Survival Analysis | 4 | 2019 | 10101 | 0.040 |
Why?
|
Thymus Neoplasms | 1 | 2002 | 274 | 0.040 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2001 | 168 | 0.040 |
Why?
|
Autoimmunity | 1 | 2008 | 1361 | 0.040 |
Why?
|
Education, Medical, Continuing | 2 | 2017 | 829 | 0.040 |
Why?
|
Species Specificity | 1 | 2004 | 2415 | 0.040 |
Why?
|
Macaca | 1 | 2001 | 413 | 0.040 |
Why?
|
Seroepidemiologic Studies | 1 | 2001 | 404 | 0.040 |
Why?
|
Breeding | 1 | 1999 | 49 | 0.040 |
Why?
|
Asia | 1 | 2001 | 629 | 0.040 |
Why?
|
Esophagus | 1 | 2005 | 1042 | 0.040 |
Why?
|
Blood Transfusion | 1 | 2005 | 1309 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2004 | 3055 | 0.040 |
Why?
|
Epithelium | 1 | 2003 | 1607 | 0.040 |
Why?
|
Adenosine Triphosphate | 2 | 2015 | 2004 | 0.040 |
Why?
|
Disease Progression | 1 | 2016 | 13671 | 0.040 |
Why?
|
Antibodies, Heterophile | 1 | 1998 | 128 | 0.040 |
Why?
|
Africa | 1 | 2001 | 725 | 0.040 |
Why?
|
Hypersensitivity | 1 | 2007 | 1172 | 0.040 |
Why?
|
Cytokines | 3 | 2018 | 7453 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2013 | 8542 | 0.040 |
Why?
|
Primates | 1 | 2001 | 520 | 0.040 |
Why?
|
Body Temperature | 3 | 1999 | 780 | 0.040 |
Why?
|
Animals, Inbred Strains | 1 | 1997 | 13 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2022 | 65371 | 0.040 |
Why?
|
Zoonoses | 1 | 1999 | 180 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39348 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2002 | 1791 | 0.030 |
Why?
|
Heart Valves | 1 | 1999 | 284 | 0.030 |
Why?
|
Trachea | 1 | 2003 | 1095 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5717 | 0.030 |
Why?
|
Genome, Viral | 1 | 2001 | 674 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2012 | 12800 | 0.030 |
Why?
|
Lymphocyte Depletion | 1 | 1998 | 605 | 0.030 |
Why?
|
Fundoplication | 1 | 2017 | 145 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2005 | 2167 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2002 | 1561 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2019 | 991 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 1997 | 794 | 0.030 |
Why?
|
Bronchi | 1 | 2019 | 850 | 0.030 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2015 | 510 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10873 | 0.030 |
Why?
|
Respiratory Insufficiency | 1 | 2004 | 1240 | 0.030 |
Why?
|
Manometry | 1 | 2017 | 459 | 0.030 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 1999 | 545 | 0.030 |
Why?
|
Radiography | 1 | 2005 | 6983 | 0.030 |
Why?
|
Mannitol | 1 | 2014 | 176 | 0.030 |
Why?
|
Prolactin | 1 | 1996 | 627 | 0.030 |
Why?
|
Disaccharides | 1 | 2014 | 170 | 0.030 |
Why?
|
Organ Preservation Solutions | 1 | 2014 | 104 | 0.030 |
Why?
|
Organ Size | 1 | 1999 | 2267 | 0.030 |
Why?
|
Histidine | 1 | 2014 | 301 | 0.030 |
Why?
|
Ethics, Medical | 1 | 1999 | 785 | 0.030 |
Why?
|
Electrolytes | 1 | 2014 | 279 | 0.030 |
Why?
|
Pulsatile Flow | 1 | 2014 | 320 | 0.030 |
Why?
|
Glutamates | 1 | 2014 | 385 | 0.030 |
Why?
|
Organ Specificity | 1 | 2018 | 1968 | 0.030 |
Why?
|
Sus scrofa | 1 | 2014 | 430 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2005 | 10474 | 0.030 |
Why?
|
Triiodothyronine | 1 | 1994 | 492 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 687 | 0.030 |
Why?
|
Menstrual Cycle | 1 | 1996 | 546 | 0.030 |
Why?
|
Perioperative Period | 1 | 2013 | 253 | 0.020 |
Why?
|
HTLV-I Antibodies | 1 | 1991 | 35 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 1999 | 1854 | 0.020 |
Why?
|
Genotype | 1 | 2006 | 13045 | 0.020 |
Why?
|
Glutathione | 1 | 2014 | 589 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2017 | 812 | 0.020 |
Why?
|
AIDS Vaccines | 1 | 1998 | 900 | 0.020 |
Why?
|
Leukemia, T-Cell | 1 | 1991 | 102 | 0.020 |
Why?
|
HTLV-I Infections | 1 | 1991 | 104 | 0.020 |
Why?
|
HIV Envelope Protein gp120 | 2 | 1998 | 925 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2025 | 3114 | 0.020 |
Why?
|
Aorta | 1 | 1999 | 2045 | 0.020 |
Why?
|
Wakefulness | 2 | 1996 | 1284 | 0.020 |
Why?
|
Thyroxine | 1 | 1994 | 665 | 0.020 |
Why?
|
Cold Temperature | 1 | 2014 | 791 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2015 | 19015 | 0.020 |
Why?
|
Patient Selection | 1 | 2022 | 4260 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 8054 | 0.020 |
Why?
|
Darkness | 2 | 2000 | 160 | 0.020 |
Why?
|
Stents | 1 | 2022 | 3195 | 0.020 |
Why?
|
Regression Analysis | 1 | 1999 | 6340 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4912 | 0.020 |
Why?
|
Sleep | 4 | 2000 | 4819 | 0.020 |
Why?
|
Hemodynamics | 1 | 1999 | 4194 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 1667 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 1999 | 3711 | 0.020 |
Why?
|
Neoadjuvant Therapy | 2 | 2009 | 2907 | 0.020 |
Why?
|
Lymphocyte Activation | 3 | 2011 | 5505 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2008 | 220 | 0.020 |
Why?
|
Rats | 1 | 2004 | 23760 | 0.020 |
Why?
|
Papio anubis | 1 | 2007 | 23 | 0.020 |
Why?
|
Organisms, Genetically Modified | 1 | 2007 | 63 | 0.020 |
Why?
|
Complement C3a | 1 | 2007 | 66 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2007 | 6568 | 0.020 |
Why?
|
Vital Capacity | 1 | 2010 | 996 | 0.020 |
Why?
|
Lymphocytes | 2 | 1992 | 2614 | 0.020 |
Why?
|
Prothrombin | 1 | 2007 | 194 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2012 | 5349 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2862 | 0.020 |
Why?
|
Phototherapy | 1 | 1989 | 368 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2007 | 406 | 0.020 |
Why?
|
HIV | 2 | 1991 | 1597 | 0.020 |
Why?
|
Vascular Patency | 1 | 2009 | 917 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2011 | 1563 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3436 | 0.020 |
Why?
|
Simian immunodeficiency virus | 1 | 1991 | 814 | 0.020 |
Why?
|
Sex Characteristics | 1 | 1996 | 2650 | 0.020 |
Why?
|
Endothelium | 1 | 2008 | 768 | 0.020 |
Why?
|
Gastroscopy | 1 | 2006 | 213 | 0.020 |
Why?
|
Complement Activation | 1 | 2007 | 447 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2010 | 1831 | 0.010 |
Why?
|
United States | 4 | 2017 | 73039 | 0.010 |
Why?
|
Mice | 2 | 2004 | 82029 | 0.010 |
Why?
|
Perioperative Care | 1 | 2012 | 1043 | 0.010 |
Why?
|
Vascular Resistance | 1 | 2007 | 939 | 0.010 |
Why?
|
Risk Factors | 3 | 2010 | 74944 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3620 | 0.010 |
Why?
|
Platelet Activation | 1 | 2007 | 644 | 0.010 |
Why?
|
Cadaver | 1 | 2008 | 1363 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 24315 | 0.010 |
Why?
|
Survival Rate | 2 | 2009 | 12840 | 0.010 |
Why?
|
Living Donors | 1 | 2008 | 647 | 0.010 |
Why?
|
Esophagoscopy | 1 | 2005 | 398 | 0.010 |
Why?
|
Waiting Lists | 1 | 2008 | 779 | 0.010 |
Why?
|
Antibodies | 1 | 2011 | 2421 | 0.010 |
Why?
|
Oxygen | 1 | 2014 | 4270 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 1992 | 2211 | 0.010 |
Why?
|
Melatonin | 2 | 1999 | 670 | 0.010 |
Why?
|
Cohort Studies | 2 | 2017 | 41754 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6847 | 0.010 |
Why?
|
Informed Consent | 1 | 2008 | 1010 | 0.010 |
Why?
|
Drainage | 1 | 2006 | 1183 | 0.010 |
Why?
|
Chronobiology Phenomena | 1 | 2000 | 29 | 0.010 |
Why?
|
Carcinoma, Large Cell | 1 | 2001 | 114 | 0.010 |
Why?
|
Aging | 1 | 1999 | 8744 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 2005 | 1695 | 0.010 |
Why?
|
Hydrocortisone | 2 | 1999 | 1841 | 0.010 |
Why?
|
Cercocebus atys | 1 | 1999 | 12 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15948 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2009 | 1456 | 0.010 |
Why?
|
Boston | 1 | 2012 | 9374 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12077 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2008 | 6514 | 0.010 |
Why?
|
Immunologic Factors | 1 | 2007 | 1596 | 0.010 |
Why?
|
Haplotypes | 1 | 2004 | 2722 | 0.010 |
Why?
|
CD40 Ligand | 1 | 1999 | 528 | 0.010 |
Why?
|
Gene Deletion | 1 | 2005 | 2675 | 0.010 |
Why?
|
Odds Ratio | 1 | 2009 | 9669 | 0.010 |
Why?
|
Bronchoscopy | 1 | 2002 | 914 | 0.010 |
Why?
|
Tunica Intima | 1 | 1998 | 459 | 0.010 |
Why?
|
Follicular Phase | 1 | 1996 | 143 | 0.010 |
Why?
|
Luteal Phase | 1 | 1996 | 138 | 0.010 |
Why?
|
Adenocarcinoma | 2 | 2005 | 6395 | 0.010 |
Why?
|
Suprachiasmatic Nucleus | 1 | 1996 | 141 | 0.010 |
Why?
|
Urine | 1 | 1996 | 362 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1998 | 794 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2007 | 5151 | 0.010 |
Why?
|
Smoking | 1 | 2010 | 9092 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2001 | 2914 | 0.010 |
Why?
|
HTLV-I Antigens | 1 | 1991 | 7 | 0.010 |
Why?
|
Genes, pX | 1 | 1991 | 7 | 0.010 |
Why?
|
Retroviruses, Simian | 1 | 1991 | 12 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1999 | 1793 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 1992 | 114 | 0.010 |
Why?
|
Gene Products, tax | 1 | 1991 | 51 | 0.010 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1992 | 176 | 0.010 |
Why?
|
Prognosis | 1 | 2012 | 30010 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 1991 | 342 | 0.010 |
Why?
|
Lymphocyte Subsets | 1 | 1992 | 313 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11095 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1998 | 2204 | 0.010 |
Why?
|
Immunoglobulin Variable Region | 1 | 1990 | 420 | 0.000 |
Why?
|
Models, Biological | 2 | 1999 | 9495 | 0.000 |
Why?
|
Molecular Sequence Data | 2 | 1991 | 17622 | 0.000 |
Why?
|
Antibody Specificity | 1 | 1990 | 1065 | 0.000 |
Why?
|
Antibodies, Viral | 2 | 1991 | 3216 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1996 | 6229 | 0.000 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1990 | 648 | 0.000 |
Why?
|
Burundi | 1 | 1987 | 12 | 0.000 |
Why?
|
Prospective Studies | 1 | 2012 | 54926 | 0.000 |
Why?
|
Deltaretrovirus | 1 | 1987 | 162 | 0.000 |
Why?
|
Cameroon | 1 | 1987 | 79 | 0.000 |
Why?
|
Democratic Republic of the Congo | 1 | 1987 | 87 | 0.000 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1999 | 4415 | 0.000 |
Why?
|
Zambia | 1 | 1987 | 273 | 0.000 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2001 | 4058 | 0.000 |
Why?
|
DNA, Viral | 1 | 1991 | 2204 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1992 | 6124 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2002 | 9419 | 0.000 |
Why?
|
Kenya | 1 | 1987 | 757 | 0.000 |
Why?
|
Rabbits | 1 | 1990 | 4772 | 0.000 |
Why?
|
Blotting, Western | 1 | 1990 | 5027 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1991 | 6082 | 0.000 |
Why?
|
Tanzania | 1 | 1987 | 1407 | 0.000 |
Why?
|
HIV Seropositivity | 1 | 1987 | 966 | 0.000 |
Why?
|
Family | 1 | 1991 | 3209 | 0.000 |
Why?
|
Base Sequence | 1 | 1991 | 12421 | 0.000 |
Why?
|
HIV-1 | 1 | 1998 | 6961 | 0.000 |
Why?
|
HIV Antibodies | 1 | 1987 | 1341 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1990 | 13421 | 0.000 |
Why?
|
Child | 1 | 2001 | 80917 | 0.000 |
Why?
|